Open in interactive viewer → charts, metric popovers & call review

RadNet's $350 Million Hospital Bet

Record imaging quarter meets a teleradiology acquisition that could remake the equity story — if Digital Health can turn ARR into profit.
RDNT · Earnings Call · 2026-11-09

RadNet chose an interesting moment to change its shape. The shares sit within 9.3% of their November 2024 high and have added 13.7% in the last 90 trading days, so this was not a beaten-down name using a deal to distract from weak operations. The quarter itself was strong: revenue rose 22.1% to $638.3 million, adjusted EBITDA rose 23.8% to $105 million, and overall procedure volume grew 10.8% in aggregate and 3.2% on a same-center basis. Total revenue was $623 million in the latest filed quarter, up 25% year over year before Q3 printed even higher.

The record quarter is not the story

The real change is strategic. RadNet agreed to acquire ONRAD, a teleradiology and hospital radiology staffing business with more than 130 contracted radiologists serving over 225 hospitals across 26 states. The price is $350 million of cash plus 5 million shares, with an earn-out of 15x every dollar of 2027 EBITDA above $56 million, payable in cash or stock. Management expects ONRAD to contribute $190 million to $200 million of revenue and $60 million to $65 million of adjusted EBITDA in its first year, at margins above 30%. Upon closing, it becomes RadNet's third reportable segment, Radiology Professional Services.

ONRAD is a capital-light, high-margin business that has grown revenues between 10% and 20% over the last several years and adjusted EBITDA margins exceeding 30%, and we expect it to add $190 million to $200 million of revenue and $60 million to $65 million of adjusted EBITDA in its first year of operation after closing.

Howard Berger, Chief Executive Officer · 2026-11-09

This is not a random adjacency. On the prior call, Howard Berger mused that teleradiology could eventually become something RadNet insources rather than outsources. “the future for RadNet could involve looking at teleradiology as more of an insourced rather than an outsourced responsibility” — Howard G. Berger, CEO · 2026-08-10 — and ONRAD is that thought turned into a transaction. It also gives DeepHealth a direct distribution channel into the hospital radiology department, where RadNet has historically been an outsider looking in through joint ventures.

Digital Health: growth is real, profit is not yet

The Digital Health segment remains the growth engine. “Annual recurring revenue, ARR, ended the quarter at $112.6 million, up 67% from September 30, 2025” — Cornelis Wesdorp, President and CEO of Digital Health · 2026-11-09, with external ARR more than doubling to $73 million and now 65% of the base. RadNet closed roughly $71 million of total contract value in Q3, including a $53 million long-term enterprise agreement with a U.S. teleradiology service provider, and the pipeline has grown from just over $100 million to more than $300 million. Management is guiding to more than $140 million of ARR by year-end and a Q4 revenue ramp of about 20% sequentially.

But the segment's profit is still thin. Digital Health adjusted EBITDA was $3.0 million versus $3.5 million a year earlier, even as revenue rose 33% to $32.9 million. Margin improved sequentially from 7.6% to 9.1%, and management blames the year-over-year decline on commercial and implementation investment plus temporary GLEAMER dilution. The prior call framed 2026 as the trough: “the Investor Day presentation that we gave towards margins of 20%-plus remains unchanged. If not, we are more positive on the outlook for that.” — Cornelis Wesdorp, President and CEO of Digital Health · 2026-08-10 Investors now have to underwrite a Q4-heavy conversion of ARR into revenue and a 2027 cost-synergy story, not a steady-state margin business.

The capacity machine and the reimbursement tax

In imaging centers, RadNet is doing what it has done for several quarters: pushing more volume through fixed costs. Advanced imaging mix rose 232 basis points to 30.6% of procedural volume, and Imaging Center adjusted EBITDA rose 25.3% with a 511 basis point margin improvement. The tools are increasingly concrete. Draft reporting now covers over 30% of RadNet exams and is targeted for full deployment by Q1 2027; clinical AI covers more than 50% of studies today, with a goal of 75% by Q3 2027. Breast ultrasound AI began rolling out across RadNet in October, following the thyroid template. The goal, as Berger put it, is “to make all of our radiologists more productive, perhaps even by 50% or more” — Howard Berger, Chief Executive Officer · 2026-11-09.

The front office is changing too. Patient registration is live at roughly 30 centers, and Sham Sokka said that in those sites “about one in three right now are fully going through digital without having to touch any front desk staff” — Sham Sokka, Chief Operating and Technology Officer · 2026-11-09, with the best centers near 75%. RadNet is also leaning into de novo facilities — a theme the market tape shows working across other healthcare-facility names, not just RadNet — and now expects to open 10 sites this year rather than seven.

The regulatory offset is modest but real. CMS finalized a 2027 physician fee schedule conversion factor cut of about 2.3%, deeper than proposed. Mark Stolper estimated “the impact to RadNet's 2027 revenue will be approximately $5 million” — Mark Stolper, Executive Vice President and Chief Financial Officer · 2026-11-09. Medicare is about 25% of the business, and Congress could still soften the cut, but the final rule is a reminder that reimbursement is a persistent tax on the imaging machine. The HOPPS site-neutrality provision, meanwhile, adds pressure on hospital radiology departments — which is precisely the pressure RadNet wants to convert into joint ventures and ONRAD conversations.

The balance sheet gives RadNet room. Q3 ended with $750.6 million of cash, $590.2 million of net debt and 1.66x net leverage. The latest filed quarter showed effective net cash of -$612 million, consistent with a business that funds growth through a mix of debt and internally generated cash. Interest coverage was 2.2x in the same filing, not heroic but adequate for a company still investing heavily in capex and acquisitions.

What to watch

RadNet is no longer just an outpatient imaging roll-up with a software hobby. ONRAD makes hospital professional services a third leg, and the professional services label is now a real segment rather than a slide. The bull case is that DeepHealth tools make ONRAD's radiologists more productive, that hospital relationships become a distribution channel for AI, and that imaging center capacity gains keep flowing through margins. The bear case is that Digital Health remains a low-margin work in progress and that ONRAD integration distracts from the core. The Q4 ARR print, ONRAD closing, and February 2027 guidance will settle which story the market believes.